Table 1 Antimicrobial susceptibility profiles of the P. aeruginosa isolates SK76, SK77, and SK78
SK76 | SK77 | SK78 | ||||
|---|---|---|---|---|---|---|
MIC (mcg / ml) | MIC (mcg / ml) | MIC (mcg / ml) | ||||
Amikacin | 16 | I | > 16 | R | 16 | I |
Gentamicin | > 4 | R | > 4 | R | > 4 | R |
Tobramycin | > 4 | R | > 4 | R | > 4 | R |
Ciprofloxacin | > 1 | R | 0.5 | S | > 1 | R |
Levofloxacin | > 2 | R | 1 | S | > 2 | R |
Colistin | < 2 | S | < 2 | S | < 2 | S |
Piperacillin/tazobactam | < 8 | S | > 16 | R | > 16 | R |
Piperacillin | < 8 | S | > 16 | R | > 16 | R |
Cefepime | > 8 | R | > 8 | R | > 8 | R |
Ceftazidime | 4 | S | > 32 | R | > 32 | R |
Ceftazidime/avibactam | < 2 | S | > 8 | R | > 8 | R |
Ceftolozane/tazobactam | < 1 | S | > 4 | R | > 4 | R |
Imipenem | > 8 | R | > 8 | R | > 8 | R |
Meropenem | 8 | I | 32 | R | 8 | I |
Fosfomycin | > 128 | R | 16 | S | 16 | S |
Aztreonam | < 1 | S | > 256 | R | > 256 | R |
VIM-type carbapenemase | neg | pos | pos | |||